JINYANGPHARM

The current price of 007370 is 5450 KRW — it has increased by 0.74% in the past 24 hours.

Depending on the exchange, the stock ticker may vary. For instance, on KRX exchange JINYANGPHARM stocks are traded under the ticker 007370.

007370 stock is 1.30% volatile and has beta coefficient of 0.12. Check out the list of the most volatile stocks — is JINYANGPHARM there?

Yes, you can track JINYANGPHARM financials in yearly and quarterly reports right on TradingView.

007370 stock has fallen by 5.05% compared to the previous week, the month change is a 6.20% fall, over the last year JINYANGPHARM has showed a 9.17% decrease.

007370 net income for the last quarter is ‪984.80 M‬ KRW, while the quarter before that showed ‪3.92 B‬ KRW of net income which accounts for −74.86% change. Track more JINYANGPHARM financial stats to get the full picture.

Yes, 007370 dividends are paid annually. The last dividend per share was 150.00 KRW. As of today, Dividend Yield (TTM)% is 2.77%. Tracking JINYANGPHARM dividends might help you take more informed decisions.

JINYANGPHARM dividend yield was 2.42% in 2023, and payout ratio reached 12.77%. The year before the numbers were 2.30% and 13.45% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.

Like other stocks, 007370 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade JINYANGPHARM stock right from TradingView charts — choose your broker and connect to your account.

007370 reached its all-time high on Aug 4, 2005 with the price of 11720 KRW, and its all-time low was 910 KRW and was reached on Oct 28, 2008.
See other stocks reaching their highest and lowest prices.

As of Apr 18, 2024, the company has 215.00 employees. See our rating of the largest employees — is JINYANGPHARM on this list?

Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So JINYANGPHARM technincal analysis shows the sell today, and its 1 week rating is strong sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating JINYANGPHARM stock shows the sell signal. See more of JINYANGPHARM technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.

EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. JINYANGPHARM EBITDA is ‪11.74 B‬ KRW, and current EBITDA margin is 12.47%. See more stats in JINYANGPHARM financial statements.